Summary
Total immunoreactive glucagon (IRG) and immunoreactive glucagon of A cell origin (IRGa) were measured in the serum of normal, sham-operated and depancreatized rats, after the administration of three glucagon antagonists: insulin (5–200 mU/rat/h), somatostatin (SRIF; 100 μg/kg/h) and antiglucagon serum (AGS, enough to bind three times the calculated total amount of circulating IRG). Since no differences were noted between the responses of normal and sham-operated animals, the values were pooled and used as controls. Pancreatectomy caused a significant increase in serum glucose, IRGa and total IRG and a significant decrease in serum insulin. AGS and SRIF significantly decreased serum glucose in control, but not in depancreatized rats, even though SRIF caused a significant decrease of IRGa in all animals. SRIF significantly decreased plasma insulin in control rats, but did not modify total IRG secretion in either group. In control rats the minimum effective hypoglycaemic dose of insulin (5 mU/rat/h) may have decreased serum IRGa, but not total IRG. At higher doses (20 mU/rat/h) insulin stimulated glucagon secretion. In depancreatized animals, higher doses of insulin (200 mU/rat/h) were needed to lower serum glucose. On the other hand, a dose of 100 μU/rat/h was sufficient to lower the serum IRG. We conclude that although hyperglucagonaemia may contribute to the hyperglycaemia of the untreated depancreatized rats, the excessive secretion of glucagon is secondary to insulin insufficiency and that, at least in this animal model, the hypoglycaemic action of insulin is only minimally dependent upon its ability to suppress glucagon secretion.
Article PDF
Similar content being viewed by others
References
Aguilar-Parada, E., Eisentraut, A.M., Unger, R.H.: Effects of starvation on plasma pancreatic glucagon in normal man. Diabetes 18, 717–723 (1969)
Bloom, S.R., Barnes, A.J., Bryant, M.G., Alberti, K.G.M.M.: Plasma glucagon in diabetes resulting from total pancreatectomy. Metabolism 25, 1481–1482 (1976)
Buchanan, K.D.: Insulin and glucose control of pancreatic glucagon release. Diabetologia 7, 473 (1971)
Buchanan, K.D., McCarroll, A.M.: Abnormalities of glucagon metabolism in untreated diabetes mellitus. Lancet 1972 II, 1394–1395
Christensen, S.E., Hansen, A.P., Iversen, J., Lundbaek, K., Ørskov, H., Seyer-Hansen, K.: Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release. Scand. J. Clin. Lab. Invest. 34, 321–325 (1974)
Dunbar, J.C., Silverman, H., Kirman, E., Foà, P.P.: Role of the submaxillary gland and of the kidney in the hyperglucagonemia of eviscerated rats. In: P.P. Foà, J. S. Bajaj, N.L. Foà (eds.): Glucagon. Its role in physiology and clinical medicine. (In press 1977)
Dunbar, J.C., Walsh, M.F., Foà, P.P.: Secretion of immunoreactive insulin and glucagon in hamsters bearing a transplantable insuloma. Diabète et Metab. (Paris) 2, 165–169 (1976)
Foà, P.P., Berger, S., Santamaria, L., Smith, J.A., Weinstein, H.R.: Extraction of the hyperglycemic factor (HGF) of the pancreas with liquid ammonia. Science 117, 82–84 (1953)
Foà, P.P., Matsuyama, T., Foà, N.L.: Radioimmunoassay of glucagon. In: G.E. Abraham (ed.): Handbook of radioimmunoassay, pp. 299–318. New York: Marcel Dekker 1977
Gerich, J.E., Lovinger, R., Grodsky, G.M.: Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol, and theophylline: evidence for a preferential effect on glucagon secretion. Endocrinology 96, 749–754 (1975)
Greenwood, F.C., Hunter, W.M.: The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114–123 (1963)
Hales, C.N., Randle, P.J.: Immunoassay of insulin with insulin antibody precipitate. Biochem. J. 88, 137–146 (1963)
Laube, H., Fussgänger, R.D., Maier, V., Pfeiffer, E.F.: Hyperglucagonaemia of the isolated perfused pancreas of diabetic mice (db/db). Diabetologia 9, 400–402 (1973)
Lawrence, A.M., Kirsteins, L., Mitton, J.: Parotid gland insulin: an extrapancreatic source of insulin in rats. Diabetes 25, Suppl. 1, 328 (1976)
Lawrence, A.M., Tan, S., Hojvat, S., Kirsteins, L.: Salivary gland hyperglycemic factor: An extrapancreatic source of glucagon-like material. Science 195, 70–72 (1977)
Lefèbvre, P.J., Luyckx, A.S.: Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism 24, 1169–1176 (1975)
Leichter, S.B., Pagliara, A.S., Grieder, M.H., Pohl, S., Kipnis, D.M.: Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma. Am. J. Med. 58, 285–293 (1975)
Loreti, L., Dunbar, J.C., Chen, S., Foà, P.P.: The autoregulation of insulin secretion in the isolated pancreatic islet of lean (obob) and obese-hyperglycemic (obob) mice. Diabetologia 10, 309–315 (1974)
Mashiter, K., Harding, P.E., Chou, M., Mashiter, R.D., Stout, J., Diamond, D., Field, J.B.: Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. Endocrinology 96, 678–693 (1975)
Matsuyama, T., Foà, P.P.: Plasma glucose, insulin, pancreatic and enteroglucagon levels in normal and depancreatized dogs. Proc. Soc. Exp. Biol. Med. 147, 97–102 (1974)
Matsuyama, T., Hoffman, W.H., Dunbar, J.C., Foà, N.L., Foà, P.P.: Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment. Horm. Metab. Res. 7, 452–456 (1975)
McGavran, M.H., Unger, R.H., Recant, L., Polk, H.C., Kilo, C., Levin, M.E.: A glucagon-secreting alpha-cell carcinoma of the pancreas. N. Engl. J. Med. 274, 1408–1413 (1966)
Palmer, J.P., Werner, P.L., Benson, J.W., Ensinck, J.W.: Immunoreactive glucagon responses to arginine in three pancreatectomized humans. Metabolism 25, 1483–1485 (1976)
Penhos, J.C., Ezequiel, M., Lepp, A., Ramey, E.R.: Plasma immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) after evisceration with and without a functional liver. Diabetes 24, 637–640 (1975)
Printseva, O.I., Shubnikova, E.A.: Identification of insulin-like substance in submaxillary salivary glands of mice by the method of fluorescent antibodies. Dokl. Akad. Nauk, S.S.S.R. 233, 484 (1977)
Rocha, D.M., Santeusanio, F., Faloona, G.R., Unger, R.H.: Abnormal pancreatic alpha-cell function in bacterial infections. N. Engl. J. Med. 288, 700–730 (1973)
Sasaki, H.B., Rubalcava, B., Baetens, D., Blàzquez, E., Srikant, C.B., Orci, L., Unger, R.H.: Identification of glucagon in the gastrointestinal tract. J. Clin. Invest. 56, 135–145 (1975)
Shima, K., Foà, P.P.: A double antibody assay for glucagon. Clin. Chim. Acta 22, 511–520 (1968)
Sutherland, E.W., Cori, C.F., Haynes, R., Olsen, N.S.: Purification of the hyperglycemic glycogenolytic factor from insulin and from gastric mucosa. J. Biol. Chem. 180, 825–837 (1949)
Unger, R.H., Aguilar-Parada, E., Müller, W.A., Eisentraut, A.M.: Studies of pancreatic alpha-cell function in normal and diabetic subjects. J. Clin. Invest. 49, 837–848 (1970)
Valverde, I., Villaneuva, M.L., Lozano, I., Marco, J.: Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“Big Plasma Glucagon”). J. Clin. Endocrinol. Metab. 39, 1090–1098 (1974)
Villanueva, M.L., Hedo, J.A., Marco, J.: Plasma glucagon immunoreactivity in a totally pancreatectomized patient. Diabetologia 12, 613–616 (1976)
Vranic, M., Pek, S., Kawamori, R.: Increased glucagon immunoreactivity in plasma of totally depancreatized dogs. Diabetes 23, 905–912 (1974)
Whitty, A.J., Shima, K., Trubow, M., Foà, P.P.: Effect of glucagon and insulin on serum free fatty acids in normal and depancreatized dogs. Proc. Soc. Exp. Biol. Med. 130, 55–61 (1969)
Yen, S.S.C., Siler, T.M., DeVane, G.W.: Effect of somatosatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucagon levels. N. Engl. J. Med. 290, 935–938 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dunbar, J.C., Walsh, M.F. & Foà, P.P. The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats. Diabetologia 14, 53–58 (1978). https://doi.org/10.1007/BF00429708
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429708